Variant report
Variant | nsv604503 |
---|---|
Chromosome Location | chr6:110569825-110571261 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:3)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:3 , 50 per page) page:
1
No data |
No data |
No data |
No data |

No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs374037927 | chr6:110569894-110569895 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
2 | rs192455015 | chr6:110569898-110569899 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs542523477 | chr6:110569911-110569912 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs114737200 | chr6:110569965-110569966 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs528053801 | chr6:110569979-110569980 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs182423187 | chr6:110569995-110569996 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs563197151 | chr6:110570022-110570023 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs9487324 | chr6:110570105-110570106 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
9 | rs530481752 | chr6:110570125-110570126 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs542381487 | chr6:110570127-110570128 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs549964393 | chr6:110570133-110570134 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs187849171 | chr6:110570214-110570215 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs536159063 | chr6:110570274-110570275 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs549394216 | chr6:110570290-110570291 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs138273091 | chr6:110570291-110570292 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs535012644 | chr6:110570307-110570308 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs558145664 | chr6:110570360-110570361 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs76552095 | chr6:110570386-110570387 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs537517647 | chr6:110570395-110570396 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs192144080 | chr6:110570411-110570412 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs184918956 | chr6:110570452-110570453 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs9487325 | chr6:110570460-110570461 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
23 | rs140258273 | chr6:110570629-110570630 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs112086353 | chr6:110570637-110570638 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs552990688 | chr6:110570638-110570639 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs60599252 | chr6:110570641-110570642 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs572835106 | chr6:110570666-110570667 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs149216804 | chr6:110570755-110570756 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs189432496 | chr6:110570796-110570797 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs192171570 | chr6:110570845-110570846 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs2878175 | chr6:110570903-110570904 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
32 | rs543866095 | chr6:110570905-110570906 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs114933242 | chr6:110570956-110570957 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs529441588 | chr6:110570959-110570960 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs549695516 | chr6:110571093-110571094 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs9487326 | chr6:110571154-110571155 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
37 | rs528751088 | chr6:110571159-110571160 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs551824526 | chr6:110571165-110571166 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs571637301 | chr6:110571169-110571170 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs376655401 | chr6:110571240-110571241 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Uveal melanoma | 21693616 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Biliary cancer | 19435499 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Malaria | 21533027 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Autism | 21448237 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Lung cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
Autism | 22495311 | CNVD |
Gastric cancer | 17908304 | CNVD |
Biliary cancer | 20360734 | CNVD |
Breast cancer | 20360734 | CNVD |
Coronary artery disease | 20360734 | CNVD |
Crohn''s disease | 20360734 | CNVD |
Hypertension | 20360734 | CNVD |
Rheumatoid arthritis | 20360734 | CNVD |
Type 1 diabetes | 20360734 | CNVD |
Type 2 diabetes | 20360734 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Melanoma | 18172304 | CNVD |
Cancer | 21637783 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Acute lymphoblastic leukemia | 17443227 | CNVD |
T-cell lymphomas | 19863542 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Follicular lymphoma | 19010834 | CNVD |
Non-small cell lung cancer | 21044232 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Phyllodes tumor | 17334353 | CNVD |
Breast cancer | 16608533 | CNVD |
Non-small cell lung cancer | 21385341 | CNVD |
Prostate cancer | 16705090 | CNVD |
Adenoid cystic carcinoma | 17372589 | CNVD |
Ependymoma | 16718352 | CNVD |
High-proliferative meningiomas | 17937814 | CNVD |
Intracranial tumor | 16823260 | CNVD |
Monoclonal gammopathy of undetermined significance | 17077331 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Breast cancer | 16272173 | CNVD |
Prostate cancer | 18632612 | CNVD |
Diffuse large b-cell lymphoma | 18287131 | CNVD |
Urothelial carcinoma | 18382360 | CNVD |
Ovarian neoplasms | 16753589 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Wilms tumour | 21544195 | CNVD |
Leukemia | 18688285 | CNVD |
Prostate cancer | 19242612 | CNVD |
Glioma | 21046410 | CNVD |
Primary central nervous system lymphoma | 21088137 | CNVD |
Zellweger syndrome | 21572526 | CNVD |
Follicular lymphoma | 20505157 | CNVD |
Congenital diaphragmatic hernia | 21085971 | CNVD |
Malignant melanoma | 18718029 | CNVD |
Lung adenocarcinoma | 21935476 | CNVD |
Invasive pancreatic ductal carcinoma | 16982739 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Lung cancer | 18438408 | CNVD |
Breast cancer | 21858162 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Breast cancer | 17603634 | CNVD |
Chondromyxoid Fibroma | 20696777 | CNVD |
Cancer | 21183584 | CNVD |
Developmental delay | 19490664 | CNVD |
Non-muscle invasive bladder neoplasm | 19445696 | CNVD |
Acute lymphoblastic leukemia | 21098271 | CNVD |
Chronic lymphocytic leukemia | 20421269 | CNVD |
Burkitt''s lymphoma | 18698080 | CNVD |
Ovarian cancer | 21720365 | CNVD |
Basal cell lymphoma | 17170743 | CNVD |
Prostate cancer | 16573809 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
Breast cancer | 21785460 | CNVD |
High-grade prostatic intraepithelial neoplasia | 16573809 | CNVD |
Prostate cancer | 16461572 | CNVD |
Neurocytoma | 17123091 | CNVD |
Cancer | 20164920 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Breast cancer | 21364760 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Chronic lymphocytic leukemia | 17805327 | CNVD |
Cutaneous T-cell lymphoma | 21881587 | CNVD |
Autism | 17483303 | CNVD |
Chordoma | 21602918 | CNVD |
Kartagener syndrome | 16639409 | CNVD |
abnormal development | 18461090 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
Systemic lupus erythematosus | 19220326 | CNVD |
Cancer | 17160897 | CNVD |
Autism | 19546859 | CNVD |
Schizophrenia | 19546859 | CNVD |
Tourette syndrome | 19546859 | CNVD |
Acute lymphoblastic leukemia | 17229543 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Breast cancer | 17133270 | CNVD |
Follicular lymphoma | 18703704 | CNVD |
Mental retardation | 17621639 | CNVD |
Intellectual disability | 22102821 | CNVD |
Pancreatic cancer | 17952125 | CNVD |
Breast cancer | 22522925 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr6:110539000-110580200 | Weak transcription | H1 BMP4 Derived Trophoblast Cultured Cells | ES cell derived |
2 | chr6:110547000-110576600 | Weak transcription | Pancreas | Pancrea |
3 | chr6:110549400-110580400 | Weak transcription | Brain Angular Gyrus | brain |
4 | chr6:110550600-110608200 | Weak transcription | Fetal Kidney | kidney |
5 | chr6:110554000-110571400 | Weak transcription | Primary Natural Killer cells fromperipheralblood | blood |
6 | chr6:110554400-110572600 | Weak transcription | Aorta | Aorta |
7 | chr6:110555400-110570800 | Weak transcription | Primary mononuclear cells fromperipheralblood | Blood |
8 | chr6:110555600-110570000 | Weak transcription | Primary T helper cells fromperipheralblood | blood |
9 | chr6:110556000-110571400 | Weak transcription | Primary T cells from cord blood | blood |
10 | chr6:110557800-110570600 | Weak transcription | Primary B cells from cord blood | blood |
11 | chr6:110559200-110572400 | Weak transcription | Liver | Liver |
12 | chr6:110559400-110571200 | Weak transcription | Brain Inferior Temporal Lobe | brain |
13 | chr6:110559400-110572800 | Weak transcription | Primary hematopoietic stem cells G-CSF-mobilized Male | -- |
14 | chr6:110559400-110573400 | Weak transcription | Brain Hippocampus Middle | brain |
15 | chr6:110564400-110571000 | Weak transcription | Rectal Smooth Muscle | rectum |
16 | chr6:110567400-110574200 | Weak transcription | Fetal Stomach | stomach |
17 | chr6:110567400-110604600 | Weak transcription | Ovary | ovary |
18 | chr6:110567600-110604600 | Weak transcription | Duodenum Smooth Muscle | Duodenum |
19 | chr6:110568000-110570400 | Weak transcription | H9 Derived Neuron Cultured Cells | ES cell derived |
20 | chr6:110568000-110571200 | Weak transcription | HUES48 Cell Line | embryonic stem cell |
21 | chr6:110569800-110571400 | Weak transcription | Stomach Smooth Muscle | stomach |
22 | chr6:110570400-110571600 | Enhancers | H9 Derived Neuron Cultured Cells | ES cell derived |
23 | chr6:110571200-110572000 | Enhancers | HUES48 Cell Line | embryonic stem cell |